Notable Analyst Rating Changes 1/22: (BMY) (ACAD) (SPWR) Upgraded; (BIDU) (MTG) (CAFD) Downgraded
Tweet Send to a Friend
UPGRADES
Berenberg upgrades Bristol-Myers Squibb Co. (NYSE: BMY) from Hold to Buy with a price target of $77. Click ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Berenberg upgrades Bristol-Myers Squibb Co. (NYSE: BMY) from Hold to Buy with a price target of $77. Click ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
